Latest Breaking News On - புல் மையம் - Page 1 : vimarsana.com

 E-Mail A team of researchers led by Professor Yaakov Nahmias, director of the Grass Center for Bioengineering at the Hebrew University of Jerusalem and founder of Tissue Dynamic, introduced a new technological approach that has the potential to rapidly develop new drugs without the need for animal experiments. According to Professor Nahmias, Drug development is a long and expensive endeavor that is defined by multiple failures. The main reason for this failure is that clinical experiments are ultimately based on minimal information gained from animal experiment which often fail to replicate the human response. The primary animals used in drug development are rodents; mice and rats with different genetics, physiology and metabolism than humans leading to a situation where successful therapies in rodents often fail in clinical trials.

Israel generalHebrew universityYaakov nahmiasGrass centerHebrew university of jerusalemProfessor yaakov nahmiasTissue dynamicProfessor nahmiasScience translational medicineMedicine healthClinical trialsPharmaceutical scienceAnimal research rightsஇஸ்ரேல் ஜநரல்ஹீப்ரு பல்கலைக்கழகம்யாகோவ் நாஹ்மியச்